Stephen D. Goble - Concepedia

Author

Stephen D. Goble

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Goble, S.D., Goble, Stephen D., Stephen D. Goble, Stephen Goble

Publications

360

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Stephen D. Goble is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	108
2	Natural Sciences	2	2	70
3	Biochemistry	2	2	44
4	Engineering	1	1	36
5	Biomolecular Engineering	1	1	36

Stephen D. Goble

Publications

349

Citations

H-Index

Page 1

	Year	Citations
Discovery of Vibegron: A Potent and Selective β<sub>3</sub>Adrenergic Receptor Agonist for the Treatment of Overactive Bladder Scott D. Edmondson, Cheng Zhu, Nam Fung Kar, Journal of Medicinal Chemistry	2015	101
Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1 <i>H</i> -benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors Tim Cernak, Nathan J. Gesmundo, Kevin D. Dykstra, Journal of Medicinal Chemistry	2017	81
Ruthenium-Catalyzed Carboxylative Cyclization of 1,6-Diynes Hahn Kim, Stephen D. Goble, Chulbom Lee Journal of the American Chemical Society EngineeringAlkene MetathesisSingle RutheniumNatural SciencesDiversity-oriented Synthesis	2007	36
Discovery of a Potent and Orally Bioavailable CCR2 and CCR5 Dual Antagonist Alexander Pasternak, Stephen D. Goble, Mary Struthers, ACS Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceBiochemistryCcr2 PotencyMedicine	2009	34
Design, synthesis, and structure–activity relationship of novel CCR2 antagonists Shankaran Kothandaraman, Karla L. Donnely, Gabor Butora, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicineNon-peptide LigandPharmacologyNovel Ccr2 Antagonists	2008	25
Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β<sub>3</sub>Adrenergic Receptor Agonists for the Treatment of Overactive Bladder Christopher R. Moyes, Richard Berger, Stephen D. Goble, Journal of Medicinal Chemistry	2014	23
Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists Alexander Pasternak, Stephen D. Goble, Reynalda deJesus, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineDrug DiscoveryRational Drug DesignNon-peptide Ligand	2009	22
Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists Alexander Pasternak, Stephen D. Goble, Pasquale P. Vicario, Bioorganic & Medicinal Chemistry Letters Potent HeteroarylpiperidineFunctional SelectivityMedicinePharmacological AgentPharmacotherapy	2007	17
Conformational studies of 3-amino-1-alkyl-cyclopentane carboxamide CCR2 antagonists leading to new spirocyclic antagonists Alexander Pasternak, Stephen D. Goble, George A. Doss, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryHeterocyclicBiochemistryMedicineConformational Studies	2008	10

Page 1